DAVID P. LUCI - 24 Jun 2021 Form 3 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ David P. Luci
Issuer symbol
ACXP
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
3
Filing time
24 Jun 2021, 18:23:23 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACXP Common Stock 1,003,523 24 Jun 2021 Direct F1
holding ACXP Common Stock 15,083 24 Jun 2021 By spouse F1
holding ACXP Common Stock 35,000 24 Jun 2021 By child F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACXP Warrants for Common Stock 24 Jun 2021 Common Stock 6,250 $2 Direct F1
holding ACXP Warrants for Common Stock 24 Jun 2021 Common Stock 7,500 $3 Direct F1
holding ACXP Warrants for Common Stock 24 Jun 2021 Common Stock 3,125 $4 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney